Haemonetics Corporation
HAE
$81.35
$0.600.74%
NYSE
| 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.67% | -41.31% | 54.64% | 10.83% | -11.84% |
| Total Depreciation and Amortization | -1.75% | 33.71% | -25.90% | -0.66% | 0.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 81.33% | 194.95% | -236.50% | -40.76% | 182.38% |
| Change in Net Operating Assets | 147.02% | -235.35% | 234.24% | -11.59% | 65.35% |
| Cash from Operations | 539.96% | -85.08% | 166.32% | -10.36% | 278.05% |
| Capital Expenditure | -810.10% | 76.00% | -772.94% | 88.93% | -186.19% |
| Sale of Property, Plant, and Equipment | -59.60% | -87.88% | 876.49% | 32.80% | -99.07% |
| Cash Acquisitions | -- | -- | -- | 100.00% | 98.82% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 112.11% | -144.99% | 23.82% | -181.97% | -18.14% |
| Cash from Investing | 7.67% | -282.93% | 203.85% | 25.66% | 83.21% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 0.06% | 0.00% | -0.06% | -101.77% | 115.01% |
| Issuance of Common Stock | -98.40% | 2,712.86% | -96.05% | 1,310.36% | -94.30% |
| Repurchase of Common Stock | -1,469.00% | 96.81% | -33,307.57% | 99.40% | -669.68% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.33% | -33.33% | 81.88% | 99.83% | -280.27% |
| Cash from Financing | -3,034.81% | 98.39% | -11,074.64% | 101.84% | -122.42% |
| Foreign Exchange rate Adjustments | -118.48% | 50.97% | 144.59% | -247.83% | 390.80% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.45% | 1.55% | -165.31% | 147.76% | -127.26% |